S. Tinsley

发表

Translational Genomic Research: The Association between Genetic Profiles and Cognitive Functioning or Cardiac Function Among Breast Cancer Survivors Completing Chemotherapy

C. Lengacher, K. Kip, Junmin Whiting, 2022, Biological research for nursing.

Potential of Biosimilars to Increase Access to Biologics: Considerations for Advanced Practice Providers in Oncology

K. Olson, Carolyn Grande, I. Jacobs, 2018, Journal of the advanced practitioner in oncology.

Cardiovascular Adverse Events and Mitigation Strategies for Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy

Anecita P. Fadol, S. Tinsley, Lisa A. Nodzon, 2022, Journal of the advanced practitioner in oncology.

Management of transfusion-related iron overload in patients with myelodysplastic syndromes.

S. Kurtin, S. Tinsley, J. Shah, 2012, Clinical journal of oncology nursing.

Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison

H. Jim, P. Jacobsen, B. Small, 2013, Supportive Care in Cancer.

A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)

D. Steensma, J. Lancet, M. Sekeres, 2016, Clinical Cancer Research.

Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes

Daohai Yu, J. Lancet, W. Fulp, 2014, American journal of hematology/oncology.

Safety profiles of second-line tyrosine kinase inhibitors in patients with chronic myeloid leukaemia.

S. Tinsley, 2010, Journal of clinical nursing.

Practical Management of Lenalidomide-Related Rash.

S. Kurtin, S. Tinsley, J. Ridgeway, 2015, Clinical lymphoma, myeloma & leukemia.

Transitioning Patients With Iron Overload From Exjade to Jadenu

S. Tinsley, Christine M. Hoehner-Cooper, 2018, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

Testing at Baseline and Throughout Iron Chelation Therapy Frequency of Testing During Iron Chelation Therapy

S. Kurtin, S. Tinsley, J. Shah, 2018 .

A Phase II Clinical Trial Of Lenalidomide and Prednisone In Low and Intermediate-1 IPSS Risk, Non-Del (5q) MDS Patients

Ji‐Hyun Lee, J. Lancet, E. Padron, 2013 .

Practical Strategies for Management of Lenalidomide-Associated Cytopenias in Myelodysplastic Syndromes With del(5q)

S. Kurtin, S. Tinsley, J. Ridgeway, 2017, Journal of the advanced practitioner in oncology.

Lenalidomide and Prednisone in Low and Intermediate‐1 IPSS Risk, Non‐Del(5q) Patients With Myelodysplastic Syndromes: Phase 2 Clinical Trial

J. Lancet, E. Padron, C. Cogle, 2019, Clinical lymphoma, myeloma & leukemia.

A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3‐Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes

Sheng Wei, J. Lancet, J. Pinilla-Ibarz, 2019, Clinical lymphoma, myeloma & leukemia.

Erlotinib for Treatment of Myelodysplastic Syndromes: A Phase II Clinical Study

Daohai Yu, J. Lancet, Ling Zhang, 2010 .

Treatment Choices: A Quality of Life Comparison in Acute Myeloid Leukemia and High‐risk Myelodysplastic Syndrome

S. Sutton, J. Lancet, S. McMillan, 2017, Clinical lymphoma, myeloma & leukemia.

Practical Guide to Management of Lenalidomide-Related Rash in Patients With MDS

S. Kurtin, S. Tinsley, J. Ridgeway, 2015 .

Clinical characteristics and outcomes of EZH2-mutant myelodysplastic syndrome: A large single institution analysis of 1774 patients.

J. Lancet, E. Padron, O. Chan, 2022, Leukemia research.

Increased genomic instability may contribute to the development of kinase domain mutations in chronic myeloid leukemia

P. Papenhausen, J. Lancet, J. Pinilla-Ibarz, 2014, International Journal of Hematology.

Practical Guide to Bone Marrow Sampling for Suspected Myelodysplastic Syndromes

S. Kurtin, S. Tinsley, J. Ridgeway, 2017, Journal of the advanced practitioner in oncology.

Phase II Study of Lenalidomide in Combination with Rituximab for Patients with CD5+/CD20+ Hematologic Malignancies Who Relapse or Progress After Rituximab. Interim Analysis.

J. Lancet, J. Pinilla-Ibarz, E. Sotomayor, 2009 .

A Comparison of Quality of Life between Intense and Non-Intense Treatment for Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

S. Tinsley, 2015 .

Mindfulness-based stress reduction for breast cancer survivors (MBSR(BC)): evaluating mediators of psychological and physical outcomes in a large randomized controlled trial

Matthew J. Goodman, C. Lengacher, K. Kip, 2020, Journal of Behavioral Medicine.

Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS)

G. Abel, Yolanda Martins, D. Steensma, 2016, Haematologica.

Growth and Change in the Journal of Human Lactation: A Content Analysis 1985–2018

Paola A. González, J. Dodgson, A. Eden, 2019, Journal of human lactation : official journal of International Lactation Consultant Association.